NIR triggered polydopamine coated cerium dioxide nanozyme for ameliorating acute lung injury via enhanced ROS scavenging
-
Published:2024-06-08
Issue:1
Volume:22
Page:
-
ISSN:1477-3155
-
Container-title:Journal of Nanobiotechnology
-
language:en
-
Short-container-title:J Nanobiotechnol
Author:
Yin Mingjing,Lei Doudou,Liu Yalan,Qin Tao,Gao Huyang,Lv Wenquan,Liu Qianyue,Qin Lian,Jin Weiqian,Chen Yin,Liang Hao,Wang Bailei,Gao Ming,Zhang Jianfeng,Lu Junyu
Abstract
AbstractAcute lung injury (ALI) is a life threatening disease in critically ill patients, and characterized by excessive reactive oxygen species (ROS) and inflammatory factors levels in the lung. Multiple evidences suggest that nanozyme with diversified catalytic capabilities plays a vital role in this fatal lung injury. At present, we developed a novel class of polydopamine (PDA) coated cerium dioxide (CeO2) nanozyme (Ce@P) that acts as the potent ROS scavenger for scavenging intracellular ROS and suppressing inflammatory responses against ALI. Herein, we aimed to identify that Ce@P combining with NIR irradiation could further strengthen its ROS scavenging capacity. Specifically, NIR triggered Ce@P exhibited the most potent antioxidant and anti-inflammatory behaviors in lipopolysaccharide (LPS) induced macrophages through decreasing the intracellular ROS levels, down-regulating the levels of TNF-α, IL-1β and IL-6, up-regulating the level of antioxidant cytokine (SOD-2), inducing M2 directional polarization (CD206 up-regulation), and increasing the expression level of HSP70. Besides, we performed intravenous (IV) injection of Ce@P in LPS induced ALI rat model, and found that it significantly accumulated in the lung tissue for 6 h after injection. It was also observed that Ce@P + NIR presented the superior behaviors of decreasing lung inflammation, alleviating diffuse alveolar damage, as well as promoting lung tissue repair. All in all, it has developed the strategy of using Ce@P combining with NIR irradiation for the synergistic enhanced treatment of ALI, which can serve as a promising therapeutic strategy for the clinical treatment of ROS derived diseases as well.
Funder
2023 Basic Ability Improvement Project for Young and Middle-Aged Teachers in Colleges and Universities in Guangxi
Medical Appropriate Technology Development and Popularization and Application Project of Guangxi
Natural Science Foundation of Guangxi
National Natural Science Foundation of China
Key Research & Development Program of Guangxi
Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation
High-level Medical Expert Training Program of Guangxi “139” Plan Funding
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. LONG M E, MALLAMPALLI R K, HOROWITZ JC. Pathogenesis of pneumonia and acute lung injury. Clin Sci. 2022;136(10):747–69.
2. FAN E, BRODIE D, SLUTSKY A S. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA. 2018;319(7):698–710.
3. ZEMANS R L MATTHAYMA, ZIMMERMAN G A, ARABI Y M, BEITLER J R, MERCAT A, et al. Acute respiratory distress syndrome. Nat Reviews Disease Primers. 2019;5(1):18.
4. Deng J, Wang R, Huang S, Ding J, Zhou W. Macrophages-regulating nanomedicines for sepsis therapy. Chin Chem Lett. 2023;34:107588.
5. HOCHBERG C H, SEMLER M W BROWERRG. Oxygen toxicity in critically ill adults. Am J Respir Crit Care Med. 2021;204(6):632–41.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献